HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

New finding sheds light on how HIV eludes treatment by mutating

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

16 Dec 2010

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

15 Dec 2010

Researchers introduce new class of drugs for HCV patients

To improve the care for individuals infected with the hepatitis C virus, a major health problem and a leading cause of chronic liver disease around the world, nearly 200 international hepatitis experts have taken an important step in escalating the introduction of a new class of targeted therapies for HCV – direct-acting antivirals.

15 Dec 2010

New device gathers reliable data about risky sexual behavior among Ethiopian teenagers

Brown University sociologists have developed a device to gather more reliable data about risky sexual behavior among Ethiopian teenagers and young adults than conventional face-to-face interviews can produce.

15 Dec 2010

Unique device eliminates cold and flu germs in eco-friendly way

Bresslergroup, an award-winning new product development firm, has designed a unique device that allows a person to easily disinfect an entire room without labor or hazardous chemicals.

15 Dec 2010

Also in Global Health News: Drought in Middle East; HIV/AIDS, TB in Indonesia; MSF warnings over needs of HIV/AIDS patients; Non-profit at work in Uganda

Inter Press Service examines the effects a "devastating drought this fall" has had on farmers in the Middle East, particularly those living in Syria. Once "[a] large wheat exporter, the drought's impact has now forced the agriculturally self-reliant Syrian government to import the staple to meet local consumption," the news service writes.

15 Dec 2010

OpEds: Assessing Judge Hudson's decision on individual mandate

In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).

14 Dec 2010

Program reduces cervical cancer deaths among HIV-infected women in Zambia

A new study undertaken in Zambia shows that, using setting-appropriate human resources and technology, morbidity and mortality from cervical cancer among HIV-infected women can be reduced. The study’s lead author is Dr Groesbeck Parham, Professor of Gynecologic Oncology and Infectious Diseases, University of Alabama at Birmingham, and Director of the Centre for Infectious Disease Research in Zambia’s Cervical Cancer Prevention Program. The research was published in the December issue of HIV Therapy.

14 Dec 2010

Adelaide man guilty of deliberately spreading HIV

An Adelaide man, Stuart McDonald, 43, has been accused of deliberately infecting his sexual partners with HIV. He has been found guilty of two counts of endangering life.

14 Dec 2010

Myths and misunderstandings about medical male circumcision for HIV prevention

A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.

14 Dec 2010

Researchers implement life skills program to reduce HIV and drug use among South African youth

Drug use, risky sexual behavior and violence among South African youth may be reduced thanks to Penn State researchers, who will look at expanding a leisure education and life skills program to 56 South African high schools.

14 Dec 2010

New theory explains spread of infectious diseases

New research using human-networking theory may give a clearer picture of just how, exactly, infectious diseases such as the common cold, influenza, whooping cough and SARS can spread through a closed group of people, and even through populations at large.

14 Dec 2010

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.

14 Dec 2010

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

Southwest Center for HIV/AIDS received $500,000 from Go Daddy to launch the Go Daddy Women's Health Center in Phoenix. The gift was announced by Go Daddy CEO and Founder Bob Parsons at the company's annual holiday event held Saturday, December 11 at Chase Field in Phoenix. Parsons presented a 'big check' to Carol Poore, President and CEO, Southwest Center for HIV/AIDS.

14 Dec 2010

PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults

Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).

13 Dec 2010

Strategies for securing life insurance policy for pre-existing medical conditions

If you've ever been told that you can't buy life insurance due to a pre-existing medical condition or that your application was rated up due to one or more medical conditions, Life Quotes, Inc. offers these tips for securing a life insurance policy at a rate you can live with.

13 Dec 2010

OraSure commences enrollment in final study for FDA approval of OraQuick Rapid HIV-1/2 OTC test

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.

13 Dec 2010

New groundbreaking research advances understanding of HIV

It is estimated that 38 million people worldwide are currently infected with HIV and that 4.1 million more are added each year. For scientists to design treatment therapies that are effective over the long-term it is essential to learn more about how the virus mutates and develops resistance to medications.

13 Dec 2010

Argos' AGS-004 shows feasibility in in vitro models to generate DC from viremic patients

Argos Therapeutics announced today that its Arcelis HIV immunotherapy, AGS-004, showed feasibility in in vitro models to generate fully functional dendritic cells (DC) from viremic patients.

13 Dec 2010

EU, India leaders meet to discuss trade deal, some concerned deal will jeopardize drug access in developing countries

On Friday, Indian Commerce Minister Anand Sharma and EU Trade Commissioner Karel de Gucht met to "present a status report on the ongoing free trade talks" that some health advocates fear could limit the supply of generic medications in developing countries, according to Business Standard. "An EU source said the report would signal that talks had made excellent progress and should be wrapped up by early next year," according to the news service (Aiyar, 12/10).

13 Dec 2010

HIV/AIDS News and Research

Further Reading

New finding sheds light on how HIV eludes treatment by mutating

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Researchers introduce new class of drugs for HCV patients

New device gathers reliable data about risky sexual behavior among Ethiopian teenagers

Unique device eliminates cold and flu germs in eco-friendly way

Also in Global Health News: Drought in Middle East; HIV/AIDS, TB in Indonesia; MSF warnings over needs of HIV/AIDS patients; Non-profit at work in Uganda

OpEds: Assessing Judge Hudson's decision on individual mandate

Program reduces cervical cancer deaths among HIV-infected women in Zambia

Adelaide man guilty of deliberately spreading HIV

Myths and misunderstandings about medical male circumcision for HIV prevention

Researchers implement life skills program to reduce HIV and drug use among South African youth

New theory explains spread of infectious diseases

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults

Strategies for securing life insurance policy for pre-existing medical conditions

OraSure commences enrollment in final study for FDA approval of OraQuick Rapid HIV-1/2 OTC test

New groundbreaking research advances understanding of HIV

Argos' AGS-004 shows feasibility in in vitro models to generate DC from viremic patients

EU, India leaders meet to discuss trade deal, some concerned deal will jeopardize drug access in developing countries

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News